San Francisco, California
London, United Kingdom
What does it take to save a life? The Bill & Melinda Gates Foundation Global Health Division aims to harness advances in science and technology to save lives in developing countries. The Foundation works with partners to deliver proven tools - including vaccines, drugs, and diagnostics - as well as discover path-breaking new solutions that are affordable and reliable. Focus areas for investments center on infectious diseases including HIV, polio, TB, dengue and malaria, as well as diagnostics and health IT ideas that bring health interventions to those who need them most.
Bob More, Head of Venture Investing at the Gates Foundation will be in attendance on Thursday, February 19th to provide an overview presentation on the Foundation's key areas of interest and best practices when applying for funding. The Gates Foundation has made $3.6 billion in grant payments in 2013 with a total of $31.6 billion in grant payments since its inception.
Bob will be on hand to meet with a handful of applicants one-on-one.
10:30am | Registration and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ended on January 14th.
Bill & Melinda Gates Foundation Participating Representative:
Bob More | Head of Venture Investing, Bill & Melinda Gates Foundation read bio»
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until February 18th (or full).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ended on January 14th. Your application will be reviewed and you will be notified of acceptance by January 30, 2015. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.
329 Oyster Point Blvd, 3rd Floor
South San Francisco, California
Bill & Melinda Gates Foundation Representative's Biography:
Bob More | Head of Venture Investing, Bill & Melinda Gates Foundation
Bob More is the head of venture investing for the Bill & Melinda Gates Foundation and leads the Global Health Venture Initiative. Prior to his current position, More was a general partner at Frazier Healthcare and a member of the firm's Biopharma Venture Team. His other previous positions include partner at Domain Associates, a Kauffman Fellow, chief operating officer of Small Molecule Therapeutics, and positions at Pharmacia Biotech, Somatogen, and MedVest. More serves as an advisory board member for Greenspring Associates, Okapi Ventures, BioMed Realty Trust, The Medical Industry Group of the NVCA, and The Sulpizio Family Cardiovascular Center. He received a master of business administration degree from the Darden School of Business Administration at the University of Virginia and a bachelor of arts from Middlebury College.
|Connect with Bob:|
About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Poliwogg, and OrbiMed.
When & Where
JLABS Bay Area
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.